Luke S. Gill is an experienced leader with over 25 years of experience in drug development. He currently serves as the Chief Executive Officer of Lambda and Novum. Prior to joining these companies, Luke held several leadership roles in contract research organizations, including Head of Oncology and Head of Clinical Development Services, and served as an Executive Board Member.
With his extensive scientific background in drug development life-cycle, Luke has successfully taken numerous assets to market by driving multi-disciplinary teams and leading global strategic advisory committees. His expertise lies in the design and delivery of cell therapies, targeted small molecules, immune-oncology clinical development plans across rare indications, solid tumor, and hematological malignancies. As a subject matter expert, he also brings strategic global operational expertise and a consultative approach in developing novel solutions.
"With our outstanding team, we're all in to drive our global clinical research strategies. Using our experience and know-how, we're focused on making a real impact, pushing research forward, and building a healthier future for everyone."
Luke S. Gill is an experienced leader with over 25 years of experience in drug development. He currently serves as the Chief Executive Officer of Lambda and Novum. Prior to joining these companies, Luke held several leadership roles in contract research organizations, including Head of Oncology and Head of Clinical Development Services, and served as an Executive Board Member.
With his extensive scientific background in drug development life-cycle, Luke has successfully taken numerous assets to market by driving multi-disciplinary teams and leading global strategic advisory committees. His expertise lies in the design and delivery of cell therapies, targeted small molecules, immune-oncology clinical development plans across rare indications, solid tumor, and hematological malignancies. As a subject matter expert, he also brings strategic global operational expertise and a consultative approach in developing novel solutions.
"With our outstanding team, we're all in to drive our global clinical research strategies. Using our experience and know-how, we're focused on making a real impact, pushing research forward, and building a healthier future for everyone."
